BlackRock Health Sciences Trust (BME) To Go Ex-Dividend on February 13th

BlackRock Health Sciences Trust (NYSE:BME) declared a monthly dividend on Friday, January 2nd. Stockholders of record on Friday, February 13th will be given a dividend of 0.2621 per share on Friday, February 27th. This represents a c) dividend on an annualized basis and a dividend yield of 7.5%. The ex-dividend date is Friday, February 13th.

BlackRock Health Sciences Trust Stock Performance

Shares of BlackRock Health Sciences Trust stock traded up $0.12 during trading on Wednesday, reaching $42.04. The company’s stock had a trading volume of 5,066 shares, compared to its average volume of 37,080. BlackRock Health Sciences Trust has a one year low of $34.18 and a one year high of $42.51. The stock has a 50-day moving average price of $41.41 and a two-hundred day moving average price of $38.97.

Hedge Funds Weigh In On BlackRock Health Sciences Trust

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Wolverine Asset Management LLC raised its stake in BlackRock Health Sciences Trust by 30.7% during the 3rd quarter. Wolverine Asset Management LLC now owns 61,346 shares of the company’s stock worth $2,284,000 after buying an additional 14,411 shares during the period. HBK Sorce Advisory LLC grew its stake in shares of BlackRock Health Sciences Trust by 27.1% during the 2nd quarter. HBK Sorce Advisory LLC now owns 11,602 shares of the company’s stock worth $423,000 after acquiring an additional 2,476 shares in the last quarter. Cypress Capital Management LLC WY bought a new position in BlackRock Health Sciences Trust in the second quarter valued at $1,405,000. Legacy Wealth Managment LLC ID acquired a new stake in shares of BlackRock Health Sciences Trust in the second quarter valued at about $55,000. Finally, Shaker Financial Services LLC acquired a new position in shares of BlackRock Health Sciences Trust during the 2nd quarter worth approximately $8,186,000.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.